What If Your Pharmacy Platform Measured Its Own Impact?

A hospice administrator has a contract renewal on her desk. The pharmacy vendor has been in place for three years, and the renewal asks for one more. Before she signs, she tries to answer the question a board member would ask about any other line item this size: what are we getting for it?

She has invoices, organized and paid. She has a folder of monthly reports listing claims processed, fills dispensed, and formulary compliance percentages. She has anecdotes: a nurse who likes the prescribing screens, a coordinator who spends her mornings chasing rejections, a director of nursing who suspects medication costs are creeping but could not say against what. What she does not have, anywhere in the building, is evidence of impact. Nothing that says rejections went down. Nothing that says costs bent. Nothing that compares today to the day before the vendor arrived.

She cannot prove the relationship is working. She cannot prove it is failing. So she signs, because switching on a hunch feels riskier than staying on one.

That contract renewal was not a decision. It was a default. And it repeats at hospices every month, because the evidence that would turn it into a decision is exactly the evidence pharmacy vendors do not volunteer.

Activity is not impact

Look closely at a typical monthly vendor report and notice what the numbers have in common. Claims processed. Fills dispensed. Prescriptions transmitted. Calls answered. Every one of them is a measure of motion. They prove the vendor was busy. None of them measure whether anything got better.

Impact is a different kind of number. It is the rejection that never happened because the prescriber saw coverage before signing. It is the claim that processed cleanly at the counter on the first try, and the day of waiting a family never experienced. It is cost per patient day bending after go-live, measured against what it was before. Impact always compares two states: before and after.

Activity needs no baseline. Impact is impossible without one.

The baseline is the honest part

Measurement against a baseline is a commitment made in advance, and the order is what makes it honest.

Before go-live, MerlinRx works with your team to record where things actually stand: your rejection rate, your cost per patient day, your time from order to first fill, your prior authorization turnaround, and whatever measures matter most to your organization. Those numbers are written down while the old way of working is still in place, which means they cannot be reframed later. Then the platform measures the same numbers, the same way, after go-live, and monthly summaries go to your managers automatically. Nobody has to request a report to find out how it is going.

The judgment stays where it belongs. The platform surfaces the numbers and the trend; your team decides what they mean and what to do about them. A vendor that grades its own homework has told you nothing. A vendor that hands you the gradebook has told you everything it can.

Why this isn't the industry default

There is a structural reason vendor reports measure motion. A vendor paid per claim earns more when there is more motion: more fills, more transactions, more activity to report. Measuring outcomes adds nothing to that model, and an honest before-and-after could subtract from it. The reporting follows the revenue.

Tie the revenue to census instead, per patient day rather than per claim, and the incentive reverses. The vendor does well only when the hospice's days cost less and run smoother, so measuring the outcome stops being a risk and becomes the sales pitch. Measurement is not a feature bolted on for credibility. It is what alignment looks like when you have to prove it.

The same logic applies to the contract. Measurement only means something if you are free to act on what it shows. That is why the numbers travel with flexible contracting rather than long lock-ins: if the platform is not producing what we described, the data will show it, and you have options. An impact report you cannot act on is just a more detailed invoice.

What a real impact report shows

Each of those is a before-and-after. None of them can be produced by a vendor that never recorded the before.

The burden of proof belongs to the vendor

There is a reason "how do we know it's working" rarely has a good answer in hospice pharmacy. For two decades, the model handed the benefit to a vendor, the vendor reported on its own activity, and the hospice's only instrument was the invoice. We wrote recently about what comes after that model: the workload moves to the software, and the decisions come back in-house. Measurement is what makes those decisions possible. You cannot run your own benefit on numbers you cannot see, and you cannot judge a vendor on numbers it never gave you.

We built measurement into MerlinRx because the alternative is asking you to take our word for it, and no hospice should renew a six-figure relationship on anyone's word. Your numbers, your baseline, your call.